Sign in
Taking peopleNo phase

Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being

Key facts

Who runs it
Imperial College London
Where
United Kingdom3 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
27 Nov 2024
Planned end
23 Apr 2026
Type of study
Observational
Record updated
20 March 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • All patients >/= 18 years old and able to provide informed consent
  • Patients with a diagnosis of chronic pulmonary aspergillosis
  • To speak and understand English
  • Able to provide informed consent

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
20 March 2025